Progyny, Inc. Earnings Per Share, Basic and Diluted
Progyny, Inc. (PGNY) reported Earnings Per Share, Basic and Diluted of -$0.07 per share for the 3-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-03-10
- Progyny, Inc. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$0.07.
- Progyny, Inc. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$1.10.
- Progyny, Inc. earnings per share, basic and diluted for the quarter ending 2019-03-31 was $0.01, a 98.63% decline year-over-year.
- Progyny, Inc. earnings per share, basic and diluted for the quarter ending 2018-12-31 was -$0.30.
- Progyny, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.41, a 1125.00% decline from fiscal 2018.
- Progyny, Inc. earnings per share, basic and diluted for fiscal 2018 was $0.04.
- Progyny, Inc. earnings per share, basic and diluted for fiscal 2017 was -$2.37.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$0.07 10-K · filed 2020-03-10 | -$0.35 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$0.41 10-K · filed 2020-03-10 | |
| 2019-09-30 | -$1.10 10-K · filed 2020-03-10 | -$0.70 10-Q · filed 2019-12-06 | ||
| 2019-03-31 | $0.01 10-K · filed 2020-03-10 | -$0.15 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$0.31 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$0.50 derived: net income ÷ weighted average shares · filed 2021-03-01 |
| 2018-12-31 | -$0.30 10-K · filed 2020-03-10 | -$0.50 derived: net income ÷ weighted average shares · filed 2020-03-10 | -$0.72 derived: net income ÷ weighted average shares · filed 2020-03-10 | $0.04 10-K · filed 2020-03-10 |
| 2018-09-30 | -$0.20 10-K · filed 2020-03-10 | -$0.42 derived: net income ÷ weighted average shares · filed 2020-03-10 | $0.32 10-Q · filed 2019-12-06 | |
| 2018-06-30 | -$0.22 10-K · filed 2020-03-10 | -$0.50 derived: net income ÷ weighted average shares · filed 2020-03-10 | ||
| 2018-03-31 | $0.73 10-K · filed 2020-03-10 | |||
| 2017-12-31 | -$2.37 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |